DÄ internationalArchiveReferences


Infective Endocarditis

Dtsch Arztebl Int 2009; 106(28-29): 481-90. DOI: 10.3238/arztebl.2009.0481

Westphal, N; Plicht, B; Naber, C

1. Naber CK, Bauhofer A, Block M et al.: S2-Leitlinie zur Diagnostik und Therapie der infektiösen Endokarditis. Z Kardiol 2004; 93: 1005–21. MEDLINE
2. Naber CK, Al-Nawas B, Baumgartner H et al.: Prophylaxe der infektiösen Endokarditis. Kardiologe 2007; 1: 243–50.
3. Oliver R, Roberts GJ, Hooper L: Penicillins for the prophylaxis of bacterial Endocarditis in dentistry. Cochrane Database Syst Rev C004:CD003813 MEDLINE
4. Wilson W, Taubert KA, Gewitz M et al.: Prevention of infective endocarditis. Guidelines from the American Heart Association. A Guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2007; 116: 1736–54. MEDLINE
5. van der Meer JT, Thompson J, Valkenburg HA, Michel MF: Epidemiology of bacterial endocarditis in The Netherlands, II: antecedent procedures and use of prophylaxis. Arch Intern Med 1992; 152: 1869–73. MEDLINE
6. Thuny F, Di Salvo G, Belliard O, Avierinos JF, Pergola V, Rosenberg V et al.: Risk of embolism and death in infective endocarditis: prognostic value of echocardiography: a prospective multicenter study. Circulation 2005; 112: 69–75. MEDLINE
7. Erbel R, Rohmann S, Drexler M, Mohr-Kahaly S, Gerharz CD, Iversen S et al.: Improved diagnostic value of echocardiography in patients with infective endocarditis by transoesophageal approach. A prospective study. Eur Heart J 1988; 9: 43–53. MEDLINE
8. Mügge A, Daniel WG, Frank G, Lichtlen PR: Echocardiography in infective endocarditis: reassessment of prognostic implications of vegetation size determined by the transthoracic and the transesophageal approach. J Am Coll Cardiol. 1989; 14(3): 631–8. MEDLINE
9. Werner M, Andersson R, Olaison L, Hogevik H: A clinical study of culture-negative endocarditis. Medicine (Baltimore) 2003; 82: 263–73. MEDLINE
10. Durack DT, Lukes AS, Bright DK: New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med 1994; 96: 200–9. MEDLINE
11. Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T et al.: Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000; 30: 633–8. MEDLINE
12. Prendergast BD: Diagnostic criteria and problems in infective endocarditis. Heart 2004; 90: 611–3. MEDLINE
13. Steckelberg JM, Murphy JG, Ballard D et al.: Emboli in infective endocarditis: the prognostic value of echocardiography. Ann Intern Med 1991; 114: 635–40. MEDLINE
14. Revilla A, López J, Vilacosta I et al.: Definition, clinical profile, microbiological spectrum and prognostic factors of early-onset prosthetic valve endocarditis; European Heart Journal 2007; 28: 760–5. MEDLINE
15. Appelbaum PC: Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA). Int J Antimicrob Agents 2007; 30: 398–408. MEDLINE
16. Rybak M, Lomaestro B, Rotschafer JC et al.: Therapeutic monitor-ing of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. DP Am J Health Syst Pharm 2009; 66: 82–98. MEDLINE
17. Paul M, Silbiger I, Grozinsky S, Soares-Weiser K, Leibovici L : Beta lactam antibiotic monotherapy versus beta lactam, aminoglycoside antibiotic combination therapy for sepsis. Cochrane database Syst Rev 2006: CD003344. MEDLINE
18. Falagas ME, Matthaiou DK, Bliziotis IA: The role of aminoglycosides in combination with a beta-lactam for the treatment of bacterial endocarditis: a meta-analysis of comparative trials: J Antimicrob Chemother 2006; 57: 639–47. MEDLINE
19. Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr, Bolger AF, Levison ME et al.: Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications. Circulation 14; 111 (23): e394–434. MEDLINE
20. Werner M, Andersson R, Olaison L, Hogevik H: Swedish Society of Infectious Diseases Quality Assurance Study Group for Endocarditis: A 10-year survey of blood culture negative endocarditis in Sweden: aminoglycoside therapy is important for survival. Scand J Infect Dis 2008; 40: 279–85. MEDLINE
21. Fowler VG Jr, Boucher HW, Corey GR et al.: Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med 2006; 355(7): 653–65. MEDLINE
22. Falagas ME, Manta KG, Ntziora F, Vardakas KZ: Linezolid for the treatment of patients with endocarditis: a systematic review of the published evidence. J Antimicrob Chemother 2006; 58(2): 273–80. MEDLINE
23. Andrews MM, von Reyn CF: Patient selection criteria and manage-ment guidelines for outpatient parenteral antibiotic therapy for native valve infective endocarditis. Clin Infect Dis 2001; 33: 203–9. MEDLINE
24. Monteiro CA, Cobbs CG: Outpatient Management of infective endocarditis. Curr Infect Dis Rep 2001; 3: 319–27. MEDLINE
25. Delahaye F, Celard M, Roth O, de Gevigney G: Indications and optimal timing for surgery in infective endocarditis. Heart 2004; 90: 618–20. MEDLINE
e1. Geißler JH, Schlensak C, Südkamp M, Beyersdorf F: Heart valve surgery today — Indications, operative technique, and selected aspects of postoperative care in acquired valvular heart disease [Herzklappenchirurgie heute: Indiaktionsstellung, OP-Technik und ausgewählte Aspekte der Nachsorge bei erworbenen Herzklappenvitien]. Dtsch Arztebl Int 2009; 106(13): 224–34.
e2. de Kerchove L, Vanoverschelde JL, Poncelet A, Glineur D, Rubay J, Zech F, et al.: Reconstructive surgery in active mitral valve endocarditis: feasibility, safety and durability. Eur J Cardiothorac Surgery 2007; 31: 592–9. MEDLINE
e3. Sohail MR, Uslan DZ, Khan AH, Friedman PA, Hayes DL, Wilson WR, et al.: Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections. J Am Coll Cardiol 2007; 49: 1851–9. MEDLINE